E.E.S. Granules Interactions
There are 676 drugs known to interact with E.E.S. Granules (erythromycin), along with 5 disease interactions, and 2 alcohol/food interactions. Of the total drug interactions, 207 are major, 409 are moderate, and 60 are minor.
- View all 676 medications that may interact with E.E.S. Granules
- View E.E.S. Granules alcohol/food interactions (2)
- View E.E.S. Granules disease interactions (5)
Most frequently checked interactions
View interaction reports for E.E.S. Granules (erythromycin) and the medicines listed below.
- Aceta w / Codeine (acetaminophen / codeine)
- Acetaminophen-odan (acetaminophen)
- albuterol
- Ambien (zolpidem)
- Apresoline (hydralazine)
- Aranesp (darbepoetin alfa)
- Asacol (mesalamine)
- budesonide
- calcitriol
- Calcium Oyster (calcium carbonate)
- clindamycin
- clonidine
- Colestid (colestipol)
- diazepam
- DuoNeb (albuterol / ipratropium)
- famotidine
- gabapentin
- Glucotrol (glipizide)
- glycopyrrolate
- IBU (ibuprofen)
- Iron Sulfate (ferrous sulfate)
- Januvia (sitagliptin)
- Lasix (furosemide)
- levocarnitine
- melatonin
- Myfortic (mycophenolic acid)
- Nexium (esomeprazole)
- Onfi (clobazam)
- Pancreaze (pancrelipase)
- Paxil (paroxetine)
E.E.S. Granules alcohol/food interactions
There are 2 alcohol/food interactions with E.E.S. Granules (erythromycin).
E.E.S. Granules disease interactions
There are 5 disease interactions with E.E.S. Granules (erythromycin) which include:
More about E.E.S. Granules (erythromycin)
- E.E.S. Granules consumer information
- Compare alternatives
- Pricing & coupons
- Side effects
- Dosage information
- During pregnancy
- Drug class: macrolides
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.